DAY ONE BIOPHARMACEUTICALS I (DAWN) Stock Balance Sheet
NASDAQ:DAWN - Nasdaq - US23954D1090 - Common Stock - Currency: USD
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 35.62M | 124.97M | 230.78M | 85.30M | 284.30M | |||
| Marketable Securities | 417.48M | 406.75M | 135.56M | 257.00M | N/A | |||
| Receivables | 19.67M | 13.88M | N/A | N/A | N/A | |||
| Inventories | 6.54M | 3.32M | N/A | N/A | N/A | |||
| Other Current Assets | 15.11M | 13.41M | 8.93M | 5.60M | 5.10M | |||
| Total Current Assets | 494.43M | 562.33M | 375.27M | 347.90M | 289.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.82M | 4.71M | 560.00K | 700.00K | 300.00K | |||
| Investments And Advances | 183.00K | 121.00K | 214.00K | 500.00K | 200.00K | |||
| Intangibles | 19.61M | 15.63M | N/A | N/A | N/A | |||
| Total Non-Current Assets | 24.61M | 20.46M | 774.00K | 1.20M | 400.00K | |||
| TOTAL ASSETS | 519.04M | 582.79M | 376.05M | 349.10M | 289.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 42.15M | 56.47M | 25.89M | 16.20M | 6.80M | |||
| Accounts Payable | 5.09M | 3.26M | 2.58M | 300.00K | 1.70M | |||
| Other Current Liabilities | 3.98M | 13.72M | 1.04M | 200.00K | 100.00K | |||
| Total Current Liabilities | 51.22M | 73.45M | 29.51M | 16.60M | 8.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 6.98M | 6.59M | 0.00 | 400.00K | 0.00 | |||
| Total Non-Current Liabilities | 6.98M | 6.59M | 0.00 | 400.00K | 0.00 | |||
| TOTAL LIABILITIES | 58.20M | 80.04M | 29.51M | 17.00M | 8.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -620.40M | -554.08M | -458.58M | -269.70M | -127.50M | |||
| Additional Paid In Capital | 1.08B | 1.06B | 805.11M | 601.80M | 408.60M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 10.00K | 10.00K | 9.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -92.00K | 84.00K | 9.00K | -100.00K | N/A | |||
| Shares Outstanding | 102.43M | 101.12M | 87.23M | 73.50M | 62.00M | |||
| Tangible Book Value per Share | 4.31 | 4.82 | 3.97 | 4.52 | 4.53 | |||
| Total Shareholders' Equity | 460.83M | 502.75M | 346.54M | 332.00M | 281.10M | |||
| TOTAL LIABILITIES AND EQUITY | 519.04M | 582.79M | 376.05M | 349.10M | 289.80M | |||
| Statistics | ||||||||
| Current Ratio | 9.65 | 7.66 | 12.72 | 20.96 | 33.26 | |||
| Return On Assets (ROA) | -18.30% | -16.39% | -50.24% | -40.73% | -58.88% | |||
| Return On Equity (ROE) | -20.61% | -18.99% | -54.52% | -42.83% | -60.70% | |||
All data in USD , ROIC based on taxRate of 0.21